Drugs / Hirudin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06112262 | Dec 2023 → Sep 2025 overdue | — | Basma Rabiey | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hirudin | “Heparin and Hirudin” NCT06112262 ↗ |
| Action | Inhibit | “Hirudin inhibits all actions of thrombin and so effectively inhibit coagulation” NCT06112262 ↗ |